• Accueil >
  • Publications >
  • Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

1 mars 2016Clinical Pharmacokinetics

DOI : 10.1007/s40262-015-0327-6

Auteurs

Elodie Odore, François Lokiec, Esteban Cvitkovic, Mohamed Bekradda, Patrice Herait, Fabrice Bourdel, Carmen Kahatt, Emmanuel Raffoux, Anastasios Stathis, Catherine Thieblemont, Bruno Quesnel, David Cunningham, Maria E. Riveiro, Keyvan Rezaï